To date, aberrant upregulation of SCUBE3 expression has been associated with unfavorable outcomes in various tumors, including NSCLC [181], breast cancer [181], metastatic melanoma [175], and osteosarcoma [181]. This evidence concerns the gene SCUBE3 and breast carcinoma.